期刊文献+

葛根素在Caco-2细胞模型中的吸收特性 被引量:9

Uptaking characteristics of puerarin in Caco-2 model system
下载PDF
导出
摘要 目的 研究葛根素在Caco-2细胞中的吸收特性。方法 改变药物浓度、实验温度和使用合适的抑制剂,测定葛根素在Caco-2细胞中的跨膜转运特性。结果 葛根素在Caco-2细胞的转运呈现较强的方向性,随着葛根素质量浓度的增加,其表观渗透率(PDR)降低(2.1~1.4)。随着温度升高PDR增大。当加入代谢抑制剂KCN和2,4-二硝基苯酚时,葛根素的PDR降低(由1.7分别降至1.0和1.2)。当加入100mg/L维拉帕米时,A面到B面的表观渗透系数Papp(A→B)从(0.84±0.18)×10^-7cm/s增加到(1.01±0.17)×10^-7cm/s,而B面到A面的Papp(B→A)从(1.43±0.18)×10^-7cm/s降低到(1.11±0.24)×10^-7cm/s。结论 葛根素在Caco-2细胞模型中的转运受到P-糖蛋白的外排作用。 Objective To study the uptaking characteristics of puerarin in Caco-2 model system. Methods The transepithelial transporting character of puerarin across Caco-2 cells was investigated by changing the concentration, temperature of drug and using appropriate inhibitors. Results The transport of puerarin across Caco-2 cell monolayers was directional. With the increase of the concentration of puerarin, the permeability direction ratio (PDR) was decreased from 2.1 to 1.4. With the increase of temperature, PDR was increased. When the metabolic inhibitors, KCN and 2,4-dinitrophenol, were added, the PDR was decreased from 1.7 to 1.0 and 1.2, respectively. When 100 mg/L Verapamil was added, the permeability coefficient of apical to basolateral was increased from (0. 84±0.18)× 10^-7 cm/s to (1.01± 0.17) × 10^-7 cm/s, and the permeability coefficient of basolateral to apical was decreased from (1.43 ± 0. 18) × 10^-7 cm/s to (1.11 ±0.24) ×10^-7 cm/s. Conclusion The evacuation by P-glycoprotein affects the puerarin transepithelial transport across Caco-2 cells.
出处 《中草药》 CAS CSCD 北大核心 2007年第6期836-839,共4页 Chinese Traditional and Herbal Drugs
关键词 葛根素 CACO-2细胞 P-糖蛋白 puerarin Caco-2 cells P-glycoprotein
  • 相关文献

参考文献9

  • 1吴凯.葛根素注射液的临床应用[J].天津药学,2002,14(6):14-16. 被引量:10
  • 2张志荣,游学均,魏振平,何勤,李少伟.愈风宁心胶囊在兔体内的药动学和生物利用度研究[J].中国药学杂志,1997,32(4):224-226. 被引量:31
  • 3Yang H T, Wang G J. Transport and uptake characteristics of a new derivative of herherine (CPU86017) by human intestinal epithelial cell line: Caco-2[J]. Acta Pharmacol Sin, 2003, 24(12): 1185-1191.
  • 4赵小辰,王广基,孙炳伟,吴晓兰.Caco-2细胞缺氧复氧损伤后二肽载体表达及生物学功能的改变[J].中国药科大学学报,2003,34(1):74-77. 被引量:5
  • 5蒋学华,贾运涛,袁媛,陈钧,周静.Caco-2细胞模型在口服药物吸收过程研究中的应用[J].中国药学杂志,2002,37(5):325-327. 被引量:30
  • 6Haber B A, Mohn K L, Diamond R H, et al. Induction patterns of 70 genes during nine days after hepaterctomy define the temporal course of liver regeneration [J]. J Clin Invest,1993, 91:1319-1341.
  • 7Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells [J]. Biochem Biophys Res Commun, 1991, 175(3):880-885.
  • 8Earvin L, John P, Mehran Y. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers [J]. Pharm Res, 2000, 17 (10): 1168-1174.
  • 9Satio H, Inui K I. Dipeptide transporters in apical and basolateral membranes of the human intestine cell line Caco-2[J].Am J Physiol, 1993, 265: 289-293.

二级参考文献40

  • 1罗伟,李保东,杨瑞华,冯小平.葛根素治疗高血压病的临床研究[J].中国中医基础医学杂志,2000,6(5):61-63. 被引量:35
  • 2金昔陆,中国药理学报,1992年,13卷,5期,284页
  • 3金昔陆,中国药理学通报,1991年,7卷,7期,421页
  • 4Allen RH,Robert AC,Philip SB. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa[J].Pharm Res,1990,7(9):902.
  • 5Gan LL,Dhiren RT.Applications of the Caco-2 model in the design and development of orally active drugs:elucidation of biochemical and physical barriers posed by the intestinal epithelium[J].Adv Drug Deliv Rev,1997,23(1):77.
  • 6Hidalgo IJ,Raub TJ,Borchardt RT.Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability[J].Gastroenterology,1989,96(3):736.
  • 7Artursson P,Karlsson J.Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells[J].Bioche Biophy Res Commun,1991,175(3):880.
  • 8Yee S.In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth[J].Pharm Res,1997,14(6):763.
  • 9Hillgren KM,Kato A,Borchardt RT.In vitro systems for studying intestinal drug absorption[J].Med Res Rev,1995,15(1):83.
  • 10Liu DZ,Morris-Natschke SL,Kucera LS,et al.Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers[J].J Pharm Sci,1999,88(11):1169.

共引文献69

同被引文献118

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部